{"id":"normal-saline-plus-hyruan","safety":{"commonSideEffects":[{"rate":null,"effect":"Mild ocular irritation"},{"rate":null,"effect":"Temporary blurred vision"},{"rate":null,"effect":"Allergic reaction"}]},"_chembl":{"chemblId":"CHEMBL2108783","moleculeType":"Unknown"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=normal saline plus hyruan","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:23:03.811356+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:23:09.218706+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=normal saline plus hyruan","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:23:09.536298+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108783/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:23:10.487948+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This combination uses normal saline as a physiologic carrier solution paired with hyaluronic acid, a naturally occurring polysaccharide that provides viscosity and tissue protection. Hyaluronic acid acts as a lubricant and hydrating agent, commonly used in ophthalmic and orthopedic applications to reduce friction and maintain moisture in affected tissues.","oneSentence":"Normal saline combined with hyaluronic acid (Hyruan) provides hydration and viscoelastic lubrication to tissues.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:57:44.693Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:23:12.047749+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Dry eye syndrome"},{"name":"Ocular surface lubrication"},{"name":"Joint lubrication and protection"}]},"trialDetails":[{"nctId":"NCT03484091","phase":"PHASE4","title":"Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2018-04-01","conditions":"Knee Osteoarthritis","enrollment":276},{"nctId":"NCT06437054","phase":"PHASE1, PHASE2","title":"Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-09-15","conditions":"Hearing Loss, Sensorineural, Hearing Loss, Sudden, Intratympanic Injection","enrollment":26},{"nctId":"NCT05861570","phase":"NA","title":"Is Combined Steroid and Sodium Hyaluronate Hydrodilatation More Effective Than Isolated Steroid Hydrodilatation in Treating Patients With Adhesive Capsulitis","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2023-05-18","conditions":"Adhesive Capsulitis","enrollment":84},{"nctId":"NCT05220527","phase":"PHASE4","title":"Effects of Knee Injections on Patients With Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Taipei Medical University","startDate":"2020-08-01","conditions":"Knee Osteoarthritis, Injection, Effect of Drug","enrollment":60},{"nctId":"NCT01510535","phase":"PHASE3","title":"Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"LG Life Sciences","startDate":"2011-12","conditions":"Osteoarthritis of the Knee","enrollment":287}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL2108783"},"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["normal saline plus hyaluronic acid"],"phase":"marketed","status":"active","brandName":"normal saline plus hyruan","genericName":"normal saline plus hyruan","companyName":"Taipei Medical University","companyId":"taipei-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Normal saline combined with hyaluronic acid (Hyruan) provides hydration and viscoelastic lubrication to tissues. Used for Dry eye syndrome, Ocular surface lubrication, Joint lubrication and protection.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:23:12.047749+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}